Page last updated: 2024-09-04
mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Sleep Apnea Syndromes
mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Sleep Apnea Syndromes in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kumar, GK; Lee, MS; Prabhakar, NR; Raghuraman, G; Sharma, SD | 1 |
Other Studies
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Sleep Apnea Syndromes
Article | Year |
---|---|
Intermittent hypoxia activates peptidylglycine alpha-amidating monooxygenase in rat brain stem via reactive oxygen species-mediated proteolytic processing.
Topics: Amidine-Lyases; Animals; Antioxidants; Brain Stem; Disease Models, Animal; Enzyme Activation; Hypoxia; Kinetics; Male; Metalloporphyrins; Mixed Function Oxygenases; Multienzyme Complexes; Neuropeptide Y; Peptide Hydrolases; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sleep Apnea Syndromes; Substance P | 2009 |